Skip to main content

Year: 2021

Pure Extracts 1-Gram Vape Carts Continue Strong Retail Sell-Through

VANCOUVER, British Columbia, Nov. 24, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly owned subsidiary Pure Extracts Manufacturing Corp.’s branded 1 gram vape carts are continuing their strong growth with licensed retailers. Of the Company’s 24 SKUs listed across 4 provinces (British Columbia, Alberta, Saskatchewan and Ontario) in the recreational cannabis space and 9 SKUs in the medical cannabis space, the 1-gram Pure Pulls branded line of full spectrum oil (FSO) THC vapes is clearly the best seller. Product re-orders are occurring with increasing frequency with shipments usually selling-through...

Continue reading

Voxtur Bolsters SaaS Title Business with Acquisition of Benutech

Voxtur executes agreement to acquire Benutech, a leading source of innovative title data solutions and technology applications TORONTO and TAMPA, Fla., Nov. 24, 2021 (GLOBE NEWSWIRE) — Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) (“Voxtur” or the “Company”), a technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that, further to the news release issued on June 09, 2021, it has signed an agreement (“Agreement”) for the acquisition (the “Acquisition”) of all of the issued and outstanding stock of Benutech, Inc. (“Benutech”). Benutech is a preeminent source of innovative data solutions and technology applications for the real estate industry. Benutech enables real estate professionals, including lenders, investors and real estate...

Continue reading

Resonant to Participate in The Benchmark Company 10th Annual Discovery Conference on December 2, 2021

AUSTIN, Texas, Nov. 24, 2021 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter solutions developed on a robust intellectual property platform, designed to connect People and Things, today announced that management will participate in The Benchmark Company 10th Annual Discovery One-on-One Investor Conference being held virtually on Thursday, December 2, 2021. Resonant management will provide a business update to conference attendees, focusing on how industry-leading RF filter manufacturing companies are leveraging Resonant’s XBAR® filter technology to facilitate the transition to next-generation, ultra-fast wireless networks such as 5G, Wi-Fi 6/6E, and Ultra-wideband (UWB). The Benchmark Company 10th Annual Discovery Investor ConferenceDate: Thursday, December 2, 2021Available for One-on-One...

Continue reading

Assure Announces Amendment to Credit Facility to Allow Funding of Second Tranche of the Senior Term Loan for Working Capital Purposes, Increasing Access to Previously Restricted Line of Credit

DENVER, Nov. 24, 2021 (GLOBE NEWSWIRE) — Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services, is pleased to announce that it has entered into an amending agreement (the “Amending Agreement”) to its Commitment Letter dated March 8, 2021 (the “Commitment Letter”), with Centurion Financial Trust, an investment trust managed by Centurion Asset Management Inc. (“Centurion”) in respect of the Company’s $11,000,000 credit facility (the “Credit Facility”) with Centurion comprised of a $9,000,000 senior term loan (the “Senior Term Loan”), funded in two tranches of $6,000,000 and $3,000,000, and a $2,000,000 senior revolving loan (the “Revolving Loan”). The first tranche of the Senior Term Loan and the Revolving Loan were previously funded. Pursuant to the Amending...

Continue reading

Acasti Pharma CEO to Participate in the Benzinga All Access Event on December 2nd

LAVAL, Québec, Nov. 24, 2021 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan D’Alvise, President and CEO of Acasti Pharma, will be participating in the Benzinga All Access event taking place on December 2, 2021. Mrs. D’Alvise is scheduled to appear on December 2, 2021 at 12:00 P.M. Eastern Time. The event will consist of an interview hosted by Spencer Israel, Executive Producer of Benzinga TV.  The event will be broadcast live and can be viewed here. An archived recording of the presentation will be available on the investor relations section of Acasti’s website at acastipharma.com/en/investors. About Benzinga All Access Benzinga All Access is a first-of-its-kind show: part interview, part investor presentation. On All Access, Benzinga partners with companies...

Continue reading

Stran & Company, Inc. CEO to Participate in the Benzinga All Access Event on December 2nd

Quincy, MA , Nov. 24, 2021 (GLOBE NEWSWIRE) — Stran & Company, Inc. (“Stran” or the “Company”) (NASDAQ: STRN) (NASDAQ: STRNW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today announced that Andy Shape, President and CEO of Stran, will be participating in the Benzinga All Access event taking place on December 2, 2021. Mr. Shape is scheduled to present on December 2, 2021 at 11:40 A.M. Eastern Time. The event will be broadcast live and can be viewed here. An archived recording of the presentation will be available on the investor relations section of the Company’s website at ir.stran.com. About Benzinga All Access Benzinga All Access is a first-of-its-kind show: part interview, part investor presentation. On All Access, Benzinga...

Continue reading

POINT Biopharma Licenses Innovative Lu-177 Production Technology from SCK CEN (Belgian Nuclear Research Center)

POINT adds key technology to accelerate in-house no-carrier-added Lu-177 production INDIANAPOLIS and MOL, Belgium , Nov. 24, 2021 (GLOBE NEWSWIRE) — POINT Biopharma Global Inc. (NASDAQ: PNT), a company accelerating the discovery, development, and global access to life changing radiopharmaceuticals, and Studiecentrum voor Kernenergie/Centre d’Etude de l’Energie Nucléaire, also known as the Belgian Nuclear Research Center (“SCK CEN”), one of Belgium’s largest research centers with sixty-five years of experience in nuclear research and technology, today announced a technology license agreement for Lu-177 purification technology to accelerate POINT’s in-house no-carrier-added lutetium-177 (n.c.a. Lu-177) production program. Medical isotopes like Lu-177 are not commodities; some Lu-177 manufacturing processes can introduce radioactive...

Continue reading

Fireweed Zinc Announces $3.6 Million Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 24, 2021 (GLOBE NEWSWIRE) — FIREWEED ZINC LTD. (“Fireweed” or the “Company”) (TSXV: FWZ) is pleased to announce a non-brokered private placement (the “Offering”) for gross proceeds of up to CAD$3.60 million. The Offering will consist of up to 4,500,000 flow through common shares of the Company at a price of CAD$0.80 per share. The proceeds from the Offering will be used for exploration and development of the Company’s Macmillan Pass Project in Yukon, Canada; and specifically will be used to incur Canadian Exploration Expenses (“CEE”) that qualify as “flow-through mining expenditures” under the Income Tax Act (Canada), all of which will be renounced to investors. Closing of the Offering is subject...

Continue reading

BioCorRx to Participate in the Benzinga All Access Event on December 2nd

ANAHEIM, CA, Nov. 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that Lourdes Felix, CEO, CFO and Director of BioCorRx, Inc. and Brady Granier, President and Director, CEO of BioCorRx Pharmaceuticals, will be participating in the Benzinga All Access event taking place on December 2, 2021. Ms. Felix and Mr. Granier are scheduled to present on December 2, 2021 at 11:00 A.M. Eastern Time. The event will be broadcast live and can be viewed here. An archived recording of the presentation will be available on the investor relations section of the BioCorRx website at ir.biocorrx.com. About Benzinga All Access Benzinga All Access is a first-of-its-kind show: part interview,...

Continue reading

AgriFORCE CEO to Participate in Two Upcoming Virtual Investor Conferences

VANCOUVER, British Columbia, Nov. 24, 2021 (GLOBE NEWSWIRE) — AgriFORCE Growing Systems Ltd. (“the Company”) (Nasdaq: AGRI), an innovative AgTech company focused on developing and acquiring agriculture IP that advances sustainable cultivation and processing for crops across multiple verticals, announced today that Ingo Mueller, CEO of AgriFORCE, will be participating in two upcoming virtual investor conferences. Canaccord Genuity 2nd Annual AgriFood Tech Innovations ForumMr. Mueller is scheduled to present at 9:00 A.M. Eastern Time on December 2nd, 2021 during the 2nd Annual AgriFood Tech Innovation Forum, presented by Canaccord Genuity. The live audio webcast can be accessed here. For additional information on the 2nd Annual AgriFood Tech Innovations Forum, please contact Nadine Miller at nmiller@cgf.com. Benzinga All Access EventMr....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.